The placebo effect is part of every medical intervention and plays a crucial role in randomized placebo-controlled trials (RCTs). It is beneficial to maximize the placebo effect when treating patients, but it should be minimized in RCTs to estimate the true drug effect (
1). Studies have shown that the placebo effect is formed by learning mechanisms (
2), and an expert consensus has suggested that the beneficial effects of placebo can be harnessed for clinical use to improve patient outcomes (
3). In contrast to the placebo effect, adverse events can occur and symptoms can get worse through a negative placebo effect, the so-called nocebo effect (
4). Yet, to exploit placebo mechanisms in clinical practice a lot of questions remain unanswered. For this Research Topic Issue, we called for the latest research articles in the field of placebo and nocebo research. The issue comprises 38 articles from “Hypothesis and Theory” to “Reviews” and to “Original Research” articles.
After giving an overview about the underlying mechanisms of the placebo effect, such as conditioning, expectations and influencing factors,
Friesen summarizes ethical views regarding the use of the placebo effect. Until recently, it has been assumed that placebos take only effect when patients are deceived, but she encourages considering placebos as a “source of agency”, without deception and in agreement with patients’ autonomy.
Babel complements the current view about classical conditioning in the placebo effect. In fact, many studies use a combination of classical conditioning and verbal suggestions to induce placebo and nocebo effects. Due to recent studies using hidden and subliminal conditioning procedures,
Babel argues that classical conditioning is a distinct mechanism that works without conscious expectations. However, there are only a few studies limited to the area of pain and further studies are needed.